The DPP‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes

Source : https://onlinelibrary.wiley.com/doi/abs/10.1111/jdi.13543

Corresponding Author Department of Hematology, Endocrinology and Metabolism, Niigata University, Faculty of Medicine, Niigata, Japan Corresponding author: Hirohito Sone, Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, 1‐757 Asahimachi‐dori, Niigata, Niigata, Japan, 951‐8510 Email [email protected] Search for more papers by this author First published: This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.